ArticleCancer biology & therapy2025

Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia.

Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.